About this episode
Reid and Aria discuss the evolving landscape of AI, its applications in medicine, and the implications for society and governance.
Reid and Aria dig into where AI is creating real, durable value—and where they see it heading to next. Reid shares an inside look at his AI-driven drug discovery work at Manas AI, making the case that medicine could be one of the biggest opportunities in the entire AI landscape. They also explore why AI will likely shift toward a mix of specialized agents and “front doors” rather than a single dominant assistant, how enterprise vs. consumer AI revenue will evolve, and what companies like Anthropic signal about where the real business of AI is taking shape. They also touch on the role of governments in delivering AI-powered public goods, before closing with a candid conversation on political corruption, institutional trust, and why civic courage still matters.
People in this episode
Host: Reid Hoffman
Guest: Aria
Topics covered
- AI
- drug discovery
- enterprise AI
- consumer AI
- political corruption
- institutional trust
Keywords
- AI
- drug discovery
- Manas AI
- enterprise AI
- consumer AI
- political corruption
- institutional trust
Mentioned in this episode
Organizations: Manas AI, Anthropic
More episodes of Possible
- Satya Nadella on making human and token capital compound · June 5, 2026 · 1h 2m
- What it takes to trust AI | Kanjun Qiu · June 3, 2026 · 57 min
- How fast can you upskill in AI? We did a sprint to find out. · May 20, 2026 · 38 min
- Anthropic’s push into finance · May 13, 2026 · 33 min
- The artist AI can’t kill · May 6, 2026 · 1h 4m
- Divine intervention in AI · April 29, 2026 · 27 min
Explore listener stats, chart rankings, contacts and more on the Possible podcast page.